ACM
DGX icon

Alethea Capital Management’s Quest Diagnostics DGX Stock Holding History

Alethea Capital Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-5,243
Closed -$762K – 98
2021
Q3 		$762K Buy
+5,243
New +$767K 0.67% 15
2020
Q3 		– Sell
-5,677
Closed -$647K – 78
2020
Q2 		$647K Buy
+5,677
New +$602K 0.38% 22

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Alethea Capital Management's DGX Position: Q4 2021 in Review

Alethea Capital Management sold out of Quest Diagnostics (DGX) in Q4 2021, closing a stake of 5,243 shares — an estimated $762K sold.

Alethea Capital Management first reported a position in DGX in Q2 2020 and held it in 2 quarters. The position peaked at $762K in Q3 2021. 905 funds tracked by Wall St. Rank hold DGX as of Q4 2021.

  • Alethea Capital Management reported no remaining Quest Diagnostics position as of Q4 2021 after selling out during the quarter.
  • Alethea Capital Management sold 5,243 Quest Diagnostics shares in Q4 2021, an estimated $762K.
  • Alethea Capital Management first reported a position in Quest Diagnostics in Q2 2020 and held it in 2 quarters.
  • Alethea Capital Management's Quest Diagnostics position peaked at $762K in Q3 2021.
  • 905 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2021.

Based on Alethea Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.